Clinical Trial Update: Clinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to HSCT for r/r B-ALL Patients [NA]

View source ↗

Summary

A recruiting clinical trial is evaluating sequential CD19 and CD22 CAR-T cell therapy versus a single CD19 CAR bridging to hematopoietic stem cell transplantati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• CD19 CAR-T therapy (CD19-targeted CAR-T cell therapy)
• CD22 CAR T therapy (CD22 CAR T)

Snippet

Sponsor: Beijing GoBroad Hospital | Conditions: B-cell Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse | NA | Status: RECRUITING